INTRODUCTION
Adenosine receptors (ARs) belong to a superfamily of the Gprotein-coupled receptors that possess seven-transmembrane domains. To date, four subtypes of ARs have been cloned and designated A " , A #A , A #B and A $ [1] . Palmitoylation has been demonstrated to occur on one or more cysteines located in the Cterminal region of several G-protein-coupled receptors, including bovine rhodopsin [2, 3] , β # and α #A adrenergic [4, 5] , D " and D # dopamine [6, 7] , 5-hydroxytryptamine 1B [8] , metabotropic mGLUR4 glutamate [9] , luteinizing hormone\human choriogonadotropin [10] and endothelin A and B [11, 12] . All of the AR subtypes, except the A #A , have one or more consensus palmitoylation sites [13] . Reports of the functional impact of palmitoylation on G-protein-coupled receptors have been inconsistent and contradictory (see Discussion section). In several instances, palmitoylation has been noted to influence the cell surface expression of transiently expressed G-protein-coupled receptors, albeit to a variable extent. In this study we demonstrate that the recombinant hexahistidine (His ' )\Asp-Tyr-Lys-Asp-Asp-AspAsp-Lys (FLAG) (H\F)-A " AR is palmitoylated on Cys$!* and we show that a substantial fraction of receptors (60 %) that cannot be palmitoylated are, apparently, rapidly degraded. However, the fraction of non-palmitoylated receptors that escape rapid degradation appear to have a normal t "/# and to function normally. Palmitoylation has no effect on the number or distribution of H\F-A " ARs expressed in transiently transfected cells.
A "
ARs couple to inhibition of adenylate cyclase and, in atrial myocardium and neuronal tissues, to activation of K + -channels [14, 15] . In order to examine the effects of A " AR palmitoylation on K + channel conductance in this study, HEK-293 cells, stably transfected with cardiac inward rectifying K + channel (CIR), were co-transfected with A " ARs, G-protein-activated inward rectifier K + channel (GIRK1) and m2 muscarinic receptors. We demonstrate, for the first time, coupling between recombinant A " ARs and co-transfected GIRK1\CIR channels. Palmitoylation has no effect on A " AR coupling to adenylate cyclase or GIRK1\CIR. 
EXPERIMENTAL PROCEDURES Materials
N
.). [$H]CPX was from New
England Nuclear (Boston, MA, U.S.A.) ; "#&I-ABA was synthesized as described [16] . Tissue-culture reagents were from Gibco (Grand Island, NY, U.S.A.) ; restriction enzymes, competent JM109 Escherichia coli and Wizard mini-and mega-prep DNA purification systems were purchased from Promega Cooperation (Madison, WI, U.S.A.) ; adenosine deaminase and Nglycosidase F were from Boehringer Mannheim Biochemicals (Indianapolis, IN, U.S.A.) ; anti-FLAG m2 affinity gel from Kodak IBI (New Haven, CT, U.S.A.) ; Amplify fluorographic, enhanced chemiluminescence reagents and hyper-film MP from Amersham (Arlington Heights, IL, U.S.A.) ; Centricon-30 concentrators from Amicon, Inc (Beverly, MA, U.S.A.) ; Westran PVDF membranes from Schleicher and Schuell (Keene, NH, U.S.A.) ; FLAG peptide and oligonucleotides used for mutagenesis were synthesized in the Biomolecular Research Facility of the University of Virginia ; Unique site elimination (U.S.E.) mutagenesis kits from Pharmacia (Piscataway, NJ, U.S.A.) ; Hoefer semi-phor was from Hoefer Scientific Instruments (San Francisco, CA, U.S.A.). All other reagents were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.).
Expression of H/F-A 1 AR
The expression vector H\F-CLDN10B (pDoubletrouble : pDT) described previously [17] was used to prepare cDNA encoding the human A " AR (hA " AR ) extended on the N-terminus with His ' and the FLAG epitope (H\F-A " AR). To generate a mutated H\F-A " AR receptor lacking the palmitoylated cysteine, a mutagenic primer was prepared to change Cys$!* to Ala : (5h-pdG AAT GAC CAT TTC CGC GCC CAG CCT GCA CCT CCC3h). A selection primer (5h-pdCTC TTC CTT TTT CAG GCC TAT TGA AGC ATT TAT CAG G-3h) was prepared to eliminate a unique Ssp1 restriction site in the pDT vector and subsequently for selection of mutated plasmids. After annealing of both primers to the heat-denatured plasmid, primer-directed DNA polymerization was carried out using T4 DNA polymerase. The newly synthesized DNA was then digested with Ssp1 and the digested mix was used to transform repair-defective E. coli strain BMH71-18 mutants. After a second round of restriction enzyme selection, the E. coli host JM109 was transformed with the Ssp1-digested plasmid preparation. DNA products from individual colonies were isolated, and a C$!* A mutant was selected and sequenced on both strands (University of Virginia Biomolecular Research Facility).
Cell culture and transfection
Native, H\F-tagged hA " AR or a C$!* A palmitoylationdeficient mutant was transfected into CHO-K1 or HEK-293 cells by means of Lipofectin (stable expression) or Lipofectamine (transient expression). Stably transfected CHO-K1 or HEK-293 cells were maintained in Ham's F12 medium and Dulbecco's modified Eagle's medium (DMEM)\F12 medium with 10 % (v\v) fetal bovine serum, 100 units\ml penicillin, 100 µg\ml streptomycin and 0.5 mg\ml G418 respectively, in an incubator of 5 % CO # \95 % air at 37 mC.
Metabolic labelling of cells with [ 3 H]palmitic acid and affinity purification of H/F-A 1 AR
Ninety percent confluent CHO-K1 or HEK-293 cells stably expressing the H\F-A " AR or the C$!* A mutant were washed with ice-cold PBS and detached from tissue culture plates with the same buffer (for CHO-K1 cells, 5 mM EDTA was added). After washing three times with DMEM the cells were resuspended in DMEM (for CHO-K1) or DMEM\F12 (for HEK-293) supplemented with 25 mM Hepes, 5 % fetal calf serum and 0.5 mCi\ml [$H]palmitic acid, which had been dried under nitrogen, and redissolved in DMSO. After incubation at 37 mC in 5 % CO # \95 % air for 2 h, intact cells were pelleted by centrifugation at 4 mC, washed three times with ice-cold PBS and receptors were purified by anti-FLAG affinity chromatography as described in [18] .
SDS/PAGE, Western blot analysis and autoradiography
Electrophoresis was conducted according to the method of Laemmli [19] using 12 % polyacrylamide gels. Autoradiography of tritiated proteins was performed with Amplify4 according to the manufacture's protocol. The gels were dried at 80 mC for 2 h and exposed to Hyperfilm-MP at k80 mC for 7-30 days ($H). For Western analyses H\F-A " ARs were transferred onto Westran PVDF membranes and incubated with anti-FLAG m2 antibody followed by horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody.
Pulse-chase experiments
To determine the half-life of wild-type and palmitoylationdeficient hA " AR, 90 % confluent cells grown on 60-mm dishes were metabolically labelled for 2-5 h with 50-100 µCi\ml [$&S]-methionine in a total volume of 2 ml\dish in methionine-free DMEM. At time 0, cells were quickly washed with 10 % fetal calf serum\DMEM supplemented with 1 mM methionine and further incubated in the same medium. At various times, cells were washed with cold PBS and lysed in hypotonic buffer A (10 mM Hepes\20 mM EDTA, pH 7.4). Receptors were then purified by anti-FLAG affinity chromatography as described above and resolved by SDS\PAGE followed by Western transfer to nitrocellulose membranes. [$&S]-Labelled hA " ARs were detected with a PhosphoImager (Molecular Dynamics).
cAMP assays
Weakly adherent intact HEK-293 cells expressing wild-type or mutant A " ARs were detached from tissue culture plates and washed by centrifugation in PBS. After two additional washes with serum-free DMEM supplemented with 20 mM Hepes, the cells were resuspended in the same medium containing 1 unit\ml adenosine deaminase. Aliquots of cells (" 40 000\200 µl) were transferred to polypropylene test tubes and maintained for 1 h at room temperature. The cells were then transferred to a 37 mC shaker bath and various amounts of CPA and 10 µM (final) forskolin were added. After 15 min, 500 µl of 0.15 M HCl was added and lysed cells were pelleted by centrifugation at 1700 g for 10 min. Supernatant (500 µl) was removed, acetylated and assayed for acetyl cAMP by automated RIA [20] . (3) (4) (5) (6) were fabricated from square-bore borosilicate capillaries using a P-80 puller (Sutter Instruments, Novato, CA, U.S.A.). Currents were recorded using an Axopatch 200A current amplifier (Axon Instruments, Foster City, CA, U.S.A.), filtered at 10 kHz, stored on videotape using a VR-10B converter (Instrutech, Great Neck, NY, U.S.A.) and digitized at 3.0 kHz with a DAP 800 processor. The processor was also used to generate command potentials. Cells were held at a resting potential of k85 mV. Test potentials of 250 ms, incremented in steps of 10 mV from k130 mV to 40 mV, were separated by 250 ms periods at the resting potential. Currents were measured at the end of each test pulse in the absence and presence of agonists [1 µM CPA or 1 µM acetylcholine (ACh), a muscarinic receptor agonist] and plotted against the potential. The bath chamber was washed thoroughly with Tyrode's solution for 8 min between the applications of CPA and ACh.
Activation of K

Agonist-induced internalization of H/F-A 1 ARs
HEK-293 cells expressing H\F-A "
ARs were pre-treated with 10 µM CPA or vehicle (0.1 % DMSO) for various times as indicated in the Figures. Tissue culture plates were placed on ice and cells were washed and detached in ice-cold PBS. After an additional three washes with cold DMEM\F12 supplemented with 25 mM Hepes, cells were resuspended in wash buffer with adenosine deaminase (1 unit\ml). Total and internalized receptor-binding sites were measured by incubation at 4 mC for 3 h with [$H]CPX ( 10 nM, a hydrophobic cell permeant antagonist) in the absence or presence of 8-SPT (a hydrophilic cell impermeant antagonist) respectively. Non-specific binding was determined in the presence of 1 µM CPX.
Other assays
Photoaffinity labelling, radioligand binding to receptors on membranes and down-regulation of H\F-A " ARs were evaluated as described previously [18] 
RESULTS
Palmitoylation of the H/F-A 1 AR
Stably transfected CHO-K1 cells expressing a high number of H\F-hA " ARs (" 25 pmol\mg of membrane protein) were metabolically labelled with [$H]palmitic acid. The receptors were purified on an anti-FLAG column and subjected to SDS\PAGE and autoradiography. As shown in Figure 1 (lane 1), a single tritiated band migrating with an apparent molecular mass of " 40 kDa was purified. After treatment with N-glycosidase F, the palmitoylated protein shifts to a new apparent molecular mass of " 32 kDa (lane 2). The same molecular masses of the purified glycosylated and deglycosylated silver-stained H\F-A " AR proteins have been noted previously [17] . No [$H]palmitate was detected in affinity purified samples derived from CHO-K1 cells transfected with native-A " ARs (lane 3). This was to be expected, since native receptors lack the FLAG epitope required for adherence to the anti-FLAG affinity column. The tritiated protein detected in lane 1 co-migrates with receptors photoaffinity labelled with "#&I-labelled 8-cyclopentyl-3-azidophenethyl-1-propylxanthine (A z -BW-A844) (lane 4). In addition, tritium in glycosylated and deglycosylated receptors co-localizes with receptor proteins detected by Western analysis using anti-FLAG m2 monoclonal antibodies (lanes 5 and 6). Using the sensitive Western blotting techniques, the receptor appeared as a broad smear containing two or three distinct individual bands. These probably represent heterogeneously glycosylated forms of the receptors, since only a single band is detected upon deglycosylation. We conclude that the tritiated protein is the H\F-A "
AR. In several instances we saw evidence of high-molecularmass receptor aggregates (Figures 2-4) . It is not clear that such aggregates occur in membranes, since purified receptors spon- taneously aggregate in a time-and concentration-dependent manner. Neutral hydroxylamine treatment (Figure 2 ) completely removed the [$H]palmitic acid incorporated into H\F-A " AR, suggesting that palmitoylation occurs on a cysteine residue as only the thioester of cysteine is labile to hydroxylamine [21, 22] . Exposure of cells to the agonist CPA (10 µM, 30 min) had no effect on the amount of tritium incorporated into the receptor. The ratio of [$H]plamitate incorporated into the purified H\F-A " AR (jCPA\kCPA) as assessed by densitometry of autoradiographs was 1.01p0.04 (meanpS.E.M., n l 3).
Expression of wild-type and C
A palmitoylation-deficient mutant receptors
Wild-type and C$!* A mutant H\F-A " ARs were either stably or transiently transfected into CHO-K1 or HEK-293 cells. As summarized in Table 1 AR ( Figure 4A ). In addition to the predominant 40 kDa mutant receptor, a 25 kDa apparent receptor fragment was observed by Western blotting. The 25 kDa fragment was detected with antibodies directed against the Nterminally engineered FLAG epitope. Deglycosylation of receptors causes a further reduction in the apparent molecular mass of the fragment (results not shown). These results indicate that the 25 kDa protein is probably a C-terminally truncated fragment of the H\F-A " AR. In initial experiments the 25 kDa protein was observed in Western blots of the C$!* A mutant, but not the wild type H\F-A " AR ( Figure 4B ). By overloading gels it was possible to detect a small amount of receptor fragment in wild-type as well as palmitoylation-deficient mutant receptors ( Figure 4C ). Densitometric analysis indicates that the amount of this receptor fragment is 11.3p2.2-fold higher in palmitoylationdeficient mutant than in wild-type receptors (meanpS.E.M., n l 3). At steady state, the ratio of (truncated receptor)\(fulllength receptors) is about 1 : 6 for mutant receptors and 1 : 66 for wild-ype receptors. These findings suggest that the palmitoylation-deficient mutant H\F-A "
ARs are more prone to proteolytic degradation than are wild-type receptors.
Determination of the half-life of wild-type and C
A palmitoylation-deficient mutant receptors
We next set out to determine whether palmitoylation affects the half-life of receptors. HEK-293 cells stably expressing wild-type or C$!* A mutant A "
ARs were pulse-labelled with [$&S]-methionine. After a chase period, H\F-A "
ARs were purified by anti-FLAG affinity chromatography, deglycosylated and analysed by SDS\PAGE. As shown in Figure 5 (A), two forms of H\F-A "
ARs were metabolically labelled with [$&S]methionine, i.e. full-length receptors (both wild type and C$*! A mutant receptors) and corresponding C-terminally truncated mutant receptors. This proteolytic receptor fragment is not readily detected with $&S-labelled wild-type receptors. There is no significant difference in half-life between full-length wild-type (t "/# l 6.4 h) and full-length mutant (t "/# l 7.1 h) receptors ( Figure 5B) . Interestingly, the truncated form of the mutant receptor turned over much faster (" 8 times, t "/# l 0.8 h) than either full-length wild-type or full-length mutant receptors ( Figure 5C ). One possible interpretation of these results is that palmitoylation has little effect on the turn-over rate of a stable subset of full-length receptors (presumably those that are correctly folded and inserted into membrane), but palmitoylation prevents a subset of newly synthesized receptors from entering into a rapidly turning over pool.
Effect of H/F-A 1 AR palmitoylation on G-protein coupling
After establishing that Cys$!* is the palmitoylation site on the H\F-A " AR, we next set out to determine whether palmitoylation influences receptor coupling to G-proteins. Such an effect of palmitoylation has been suggested for β # -adrenergic receptors [23] . "#&I-ABA is an agonist radioligand that selectively binds to G-protein-coupled A "
ARs [24] . Antagonist radioligands, such as [$H]CPX, bind with similar affinity to all A " ARs, those that are uncoupled from G-proteins and those that are coupled [25] . We calculated the fractional coupling of A "
ARs to G-proteins from the ratio of high-affinity "#&I-ABA to [$H]CPX binding sites. The coupling ratio is similar for wild-type (41.5p7.0 %) and C$!* A palmitoylation-deficient mutant receptors (41.8p4.7 %). The sensitivity of H\F-A " ARs to uncoupling by guanine nucleotides was determined by measuring the dependence on concentation of the ability of 5h-[γ-thio]triphosphate ([S]GTP) to inhibit the Receptor-effector coupling to adenylate cyclase was evaluated by comparing the potency of CPA to inhibit cAMP production in cells expressing similar numbers of wild-type or palmitoylationdeficient H\F-A "
ARs. There was a modest difference in the potency and efficacy of CPA to inhibit forskolin-stimulated cAMP accumulation in the two cell lines. This could reflect a subtle effect of palmitoylation on receptor function (Figure 6 , bottom), but the difference is small enough that it might be attributed in part to the 22 % higher receptor expression in the wild-type compared with the palmitoylation-deficient mutant cells (Table 1) , i.e. to the difference in the number of spare receptors. Both the basal and forskolin-stimulated levels of cAMP were similar in the cell lines expressing wild-type or mutant receptors. In triplicate experiments, the calculated IC &! values for cells expressing wild-type and mutant receptors differed by a factor of less than 2 (0.11p0.02 nM compared with 0.19p0.04 nM). As a second measure of receptor-effector coupling we examined the ability of CPA to activate K ACh channels (GIRK1\CIR) co-expressed with both H\F-A " ARs and m2 muscarinic receptor. CPA (1 µM) stimulated K + channel conductance in cells expressing either wild-type or palmitoylationdeficient H\F-A " ARs ( Figure 7 ). To our knowledge this is the first instance in which recombinant ARs have been demonstrated to couple to recombinant K + channels. Representative results are shown in Figure 7 in which the agonist-induced current is plotted as a function of voltage. The I-V curves in Figures 7(A) and 7(B) exhibit inward rectification typical of the GIRK1\CIR channel. Stimulation by CPA of K + channel conductance is absent in nontransfected cells and is blocked by the selective A " AR antagonist CPX in transfected cells (results not shown). Considering that various factors may affect protein expression levels, and therefore affect the CPA-induced K + current, CPA responses were normalized to ACh responses in each cell. Normalized CPA responses were compared between wild-type and palmitoylation- deficient mutant H\F-A " AR groups using an unpaired t-test. The results showed that there is no significant difference between these two groups [CPA\ACh, 0.82p0.13 (n l 5) compared with 1.23p0.21 (n l 4) ; wild type compared with mutant, P 0.05]. We conclude from these results that palmitoylation has little effect on the coupling of A " ARs to two effectors, adenylate cyclase and K + -channels.
Palmitoylation has no effect on agonist-induced A 1 AR internalization
To determine whether palmitoylation has any influence on H\F-A " AR internalization, binding of the hydrophobic antagonist [$H]CPX to intact cells was measured in the absence and presence of the cell-impermeant ligand, 8-SPT. We anticipated that [$H]CPX would bind to both cell surface and internalized receptors, whereas 8-SPT would be restricted to a subset of receptors, presumably on the cell surface. Figure 8 shows that the percentage of internalized receptors increases approx. 3-fold, from 10 % to 30 %, during a 1 h treatment of cells with CPA, and that the palmitoylation state of the H\F-A " AR has no significant effect on the baseline level of internalized receptors, the magnitude or the kinetics of CPA-induced receptor internalization.
Effect of palmitoylation on agonist-induced receptor downregulation
CPA-induced down-regulation [18] was examined in wild-type and palmitoylation-deficient H\F-A "
ARs. As shown in Figure 9 , 24 h of exposure to CPA (10 µM) had similar effects on wild-type and mutated receptors. The CPA-induced decrease in receptor number, as determined by binding of the antagonist [$H]CPX, was 48.0p8.0 % for wild-type receptors and 37.3p3.9 % for palmitoylation-deficient mutant receptors (Table 1) . We used "#&I-ABA to evaluate the effect of CPA pretreatment on the number of G-protein-coupled receptors. CPA-induced down-
Figure 9 Effect of palmitoylation on CPA-induced down-regulation of H/F-A 1 ARs
Stably transfected HEK-293 cells were pretreated for 24 h with vehicle (0.1 % DMSO) or 10 µM CPA in the presence of 0.5 units/ml adenosine deaminase. Membranes were prepared and used for radioligand binding assays. Left : specific binding isotherms ; right : Scatchard-transformed specific binding. Each point is the meanpS.E.M. of triplicate determinations. The results are representative of three independent experiments. Binding parameters are summarized in Table 1 .
regulation of "#&I-ABA binding was similar for wild-type and palmitoylation-deficient H\F-A " ARs : wildtype, 64.3p5.4 % ; mutant, 60.0p4.4 % ( Table 1) .
DISCUSSION
Palmitoylation influences receptor trafficking and effector coupling in ways that appear to vary among individual G-proteincoupled receptors. In this study we set out to establish that the A "
AR is palmitoylated and to investigate thoroughly the influence of this modification on receptor expression, trafficking and function. We found that depalmitoylation appears to cause a subset of receptors to undergo rapid degradation, although the remaining receptors turn over at a normal rate.
The A " AR is particularly well suited for this type of study. The evaluation of radioligand binding and G-protein coupling is facilitated by the existence of high-affinity agonist and antagonist radioligands and photoaffinity labels that bind to A " ARs with high specificity [27, 28] . The H\F-receptor can be purified to near homogeneity in high yield [17] , so its labelling with [$H]palmitic acid can be assessed. A polar antagonist, 8-sulphophenyltheophylline, can be used to clearly distinguish between A " ARs on the cell surface and those in the cell interior [29] . In addition, A "
ARs are known to couple to multiple effectors. This provides an opportunity to determine whether palmitoylation has a differential effect on receptor coupling to different effectors. The results of this study indicate that palmitoylation of the A " AR has little effect on the regulation of effector coupling of recombinant receptors.
We found for the first time that non-palmitoylated A " ARs are substantially more prone ( 11-fold) to form a 25 kDa presumed receptor proteolytic fragment, suggesting that palmitoylation may affect receptor stability. Consistent with the finding were pulse-chase experiments in which we found that some palmitoylation-deficient receptors are more prone to rapid degradation than are wild-type receptors. The half-life of truncated receptors is eight times shorter than that of full-length receptors. This difference in the turn-over rate indicates that the proteolytic cleavage of the mutant A " ARs occurs intracellularly, and is not an artifact of in itro receptor purification. It is striking that there is little difference in the half-lives between full-length wild-type and full-length palmitoylation-deficient mutant A " ARs. Why might this be so ? If palmitoylation prevents receptors from rapid degradation, one might expect that non-palmitoylated receptors would all become more labile. One possible interpretation is that newly synthesized palmitoylation-deficient receptors enter into two different subcellular compartments. A proportion of receptors are stabilized, presumably by correctly folding and anchoring into a membrane. These stable full-length mutant receptors turn over at a slow rate, comparable with that for fulllength wild-type receptors. Another fraction of newly synthesized palmitoylation-deficient receptors are incorrectly folded and\or enter into a cellular compartment marked for rapid degradation. The palmitoylation-deficient full-length receptors appear to degrade with a single exponential time course with t "/# l 7.1 h, i.e. we could not detect a rapidly turning over pool. This suggests that the fraction of receptors destined for rapid turn-over are very rapidly truncated to the 25 kDa fragment size. The steady-state ratio of full-length to truncated receptors is 6 : 1 ; the t "/# of the full-length receptor pool is 7.1 h ; and the t "/# of the truncated receptor 0.8 h. If k " and k # depict the rates of degradation of the full-length and truncated receptor respectively, then k " \k # l (1\0.8)\(6\7.1)$ 1.5. By this calculation, 60 % of the total palmitoylation-deficient receptors appear to be rapidly degraded.
If this interpretation is correct, then palmitoylation apparently protects nascent receptor peptides from proteolysis and thus shifts the distribution of receptors so that more are delivered to a stable pool. Protection from degradation by palmitoylation might occur if palmitoylation reduces the delivery of receptors into cellular compartments, where they are rapidly degraded, or if it reduces the affinity of the receptor for proteases or regulators of proteases that degrade receptors. Palmitoylation may facilitate the association of receptors to docking sites that escort receptors to the cell surface. It is notable in this regard that removal of palmitate from rhodopsin with hydroxylamine dramatically increases its sensitivity to proteases [3] , and palmitoylation of the α-subunit of the G-protein, Gz, inhibits by more than 90 % its affinity for Gz GTPase-activating protein, a member of the regulators of G-protein signalling family of proteins [30] .
The notion that palmitoylation of target proteins may regulate their affinity for regulatory factors can be extended to the β # -adrenergic receptor, where palmitoylation of the receptor is thought to decrease its affinity for protein kinase A [31, 32] . However, the effect of palmitoylation to reduce β # -receptor phosphorylation cannot be generalized to other G-proteincoupled receptors. For example, palmitoylation has no effect on the phosphorylation of the α #A adrenergic receptor [33] or the V2 vasopressin receptor [34] . The general absence of an effect of palmitoylation on receptor phosphorylation is consistent with the general lack of an effect of palmitoylation on receptor desensitization.
We observed a large ( 6-fold) discrepancy in the highest B max values detected in multiple ( 20) stably transfected clones of palmitoylated wild-type receptors compared with palmitoylationdeficient C$!* A mutant receptors. This was noted both in HEK-293 cells and in CHO-K1 cells and is consistent with our suggestion that depalmitoylation enhances receptor proteolysis and average turn-over rate, and decreases receptor stability. However this effect of palmitoylation on receptor expression is not observed in transiently transfected cells. Why might this be so ? Newly synthesized receptors enter an endosomal compartment and are either delivered to the cell surface or degraded. We have suggested that palmitoylation could have the effect of shifting the distribution of receptors so that more are delivered to the cell surface and stabilized. Since transiently transfected cells express far more receptors than do stably transfected cells, the results suggest that palmitoylation influences a cell-surface targeting process that may be saturated when the rate of new receptor synthesis is high, as in transient transfection. Of note in this regard are previous studies of luteinizing hormone receptors. In stably transfected cells, palmitoylation-deficient mutants were reported to be trapped intracellularly [35] . In a later study of transiently transfected cells, no evidence for intracellular trapping of palmitoylation-deficient mutants was detected [10] . This is consistent with the possibility that the effect of palmitoylation varies markedly between stably and transiently transfected cells.
The currently published results suggest that palmitoylation has a variable influence on the coupling of various receptors to their effectors. In most instances palmitoylation has been found not to affect G-protein coupling. One possible exception is the palmitoylation-deficient endothelin A receptor, which was reported to selectively lose its ability to couple to Ca# + mobilization, whereas its ability to couple to cAMP accumulation is not affected [11] . The palmitoylation-deficient endothelin B receptor was reported to lose its ability to couple to both Ca# + mobilization and adenylate cyclase inhibition [12] . In the present study we detected minor effects of palmitoylation on A " AR coupling to inhibition of cAMP accumulation or to coupling to co-transfected GIRK1\CIR K + channels. It is possible that palmitoylation may produce subtle effects on receptor trafficking or on the affinity of the interaction between receptors and various regulatory components. Subtle regulatory effects may be masked by the use of overexpressed recombinant receptors.
Based on experiments with α #A -adrenergic receptors, Eason et al. [36] hypothesized that palmitoylation is necessary for agonistinduced down-regulation of G-protein-coupled receptors. The results of the current study represent a counter-example to this suggestion inasmuch as the palmitoylation-resistant C$!* A mutant A " ARs undergo down-regulation to nearly the same extent as do the wild-type A " ARs. We conclude that palmitoylation is not a general requirement for agonist-induced downregulation of G-protein-coupled receptors.
